Medically reviewed by Jay N. Yepuri, MD Inflammatory bowel disease (IBD) is a group of chronic (long-term) conditions that cause inflammation in the digestive tract, which includes the mouth, ...

Abivax has shared positive top-line results from two late-stage studies of its investigational oral miR-124 enhancer in adults with moderately to severely active ulcerative colitis (UC).

Abivax announces trading resumption of its ordinary shares on Euronext Paris PARIS, France, July 24, 2025 – 02:30 p.m. (CEST) – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“Abivax” or the ...

Abivax announces temporary trading halt of its ordinary shares on Euronext Paris PARIS, France, July 24, 2025 – 07:30 a.m. (CEST) – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“Abivax” or the ...

Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares ...

In a key advance for regenerative medicine and gut health, scientists from Duke-NUS Medical School and Nanyang Technological ...

ACROBiosystems is breaking the chain of chronic suffering and safeguarding intestinal health. Learn how in this article.

Relevant biomarkers include cytokines and targets such as IL-4, IgE, IL-5, IL-13, IL-33, and TSLP (Figure 2). A number of targeted drugs are currently available, including lebrikizumab, dupilumab, and ...

All securities to be sold in the Offering will be offered by the Company. The Company’s ADSs are listed on the Nasdaq Global Market under the ticker symbol "ABVX.” The Company’s Ordinary Shares are ...

Many clinicians remain unaware of the health risks linked to PFAS, short for perfluoroalkyl and polyfluoroalkyl substances, ...

Scientists discovered that telocytes in the gut send precise, neuron-like signals to intestinal stem cells via cytonemes.

In a key advance for regenerative medicine and gut health, scientists from Duke-NUS Medical School and Nanyang Technological ...